Smart, Secure, and Built to Endure – The Future of Biopharma Logistics & Cold Chain Excellence
Key Themes & Topics
Cold Chain Resilience in a Changing Market
Explore strategies to build a robust, efficient, and adaptable cold chain that can support the growing demand for biologics and biosimilars across Asia’s evolving markets.
Advanced Technologies for Biologistics
Discover how cutting-edge technologies — including IoT, data loggers, and automation — are transforming the monitoring, management, and optimization of temperature-sensitive biologics shipments.
Overcoming Supply Chain Disruptions
Share practical solutions and case studies on how to tackle disruptions such as transport shortages, temperature excursions, and global risks affecting the integrity of biologics.
Regulatory Compliance and Quality Assurance
Highlight the latest APAC regulatory updates and best practices to ensure product quality, patient safety, and transparent reporting throughout the biologics supply chain.
Collaboration Across Stakeholders
Foster collaboration among vaccine manufacturers, biologics producers, logistics providers, regulators, and technology partners to create a more integrated and sustainable distribution ecosystem.
Attendees
Companies
Speakers
About the Event
Be Part of Asia’s Premier Biopharma Logistics Gathering – BioSupply Chain Asia 2026
Join us for the 10th Annual BioSupply Chain Asia 2026, taking place on March 11–12, 2026, at Marina Bay Sands, Singapore – where the region’s top biopharma logistics leaders converge to drive innovation and resilience in cold chain and supply chain operations across the industry.
As Asia’s biopharma sector continues its rapid expansion, this milestone edition will spotlight next-generation strategies, technologies, and best practices for transporting sensitive biological products — from biologics and vaccines to cell and gene therapies. Featuring insightful keynotes, dynamic panel discussions, and high-impact networking, this is your opportunity to stay ahead of regulatory shifts, digital transformation, and sustainability imperatives in the supply chain.
Celebrate a decade of progress and be part of the conversation shaping the future of biopharma logistics in Asia.
Who Should Attend
This event is designed for Vice Presidents, Directors, and Heads of Supply Chain, Logistics, Cold Chain Management, Clinical Supply, and Quality, representing vaccine developers, biopharmaceutical companies, and biologics manufacturers across Asia-Pacific and Beyond
What to Expect
Gain strategic insights into the latest innovations in cold chain and biologics logistics, including:
- Digitally connected supply networks
- Smart packaging and traceability solutions
- High-speed, end-to-end cold chain infrastructure
- Scalable strategies for Asia's growing clinical and commercial needs
Why it Matters
The biopharma sector is rapidly expanding, with strong growth in biologics, biosimilars, and advanced therapies. Between 2025 and 2035, the biosimilars market alone is projected to grow at a CAGR of 7.5%, reaching USD 72.29 billion, driven by patent expirations and rising healthcare access across Asia. However, major logistical challenges persist. The WHO estimates that, even before COVID-19, up to 50% of vaccines were wasted annually due to poor temperature control—amounting to nearly a billion lost doses. More broadly, the pharmaceutical industry loses around USD 35 billion each year from failures in cold chain logistics.
Testimonials
“The well-structured program and engaging discussions were the highlights. The sessions provided valuable insights into emerging trends and innovations in cell and gene therapy.”
Agency for Science, Technology and Research
“The content, wide coverage of topics and perspectives from upstream manufacturing to downstream logistics. The booth and food arrangement are excellent. Prompting more networking opportunities with delegates and exhibitors.”
Becton Dickinson
“Enjoy panel discussions. Good networking opportunity.”
VivaZome Therapeutics
“Insightful sessions, exposure to new technology/products from the exhibition Having the very good opportunity to meet stakeholder, and initiate some business opportunity. Also, happy to share my knowledge as speaker.”
Daewoong Pharmaceuticals
“Good overall experience and networking opportunities. Able to network during lunch and coffee breaks. The networking opportunities are good as IMAPAC brings people to their booth.”
Welkin Engineering
“Attention to detail in planing ensured everything ran smoothly and have opportunity to meet valuable partners to collaborate and develop strong relationships.”
Zumutor Biologics
“We’ve had some good conversations with customers and potential customers.”
